ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305802 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305802; 2) Community: the network communities that were significantly associated with the response to NSC 305802; 3) Molecule: the relationships between components within communities and NSC 305802; 4) MDR: the compounds that were significantly associated with the NSC 305802.

NSC Compound Enrichment Correlation
NSC 672141 Null 0.00503396694999378 0.53047493
NSC 679108 Phenol, 4,4'-(5,5'-biisoxazole-3,3'-diyl)bis- 0.00503396694999378 0.29678368
NSC 719480 Null 0.00503396694999378 -0.067570035
NSC 740510 6-(11-aminoundecyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.00503396694999378 -0.040563284
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.00503396694999381 0.50999023
NSC 10520 Null 0.00617256681787881 0.1271578
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.00617256681787881 0.33381257
NSC 140380 Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) 0.00617256681787881 0.60467616
NSC 157381 Null 0.00617256681787881 0.37961733
NSC 287459 Cytarabine AY 0.00617256681787881 0.44866707
Total:122  Current:23    [First] [Prev] [Next] [Last]